Nefazodone

This classification denotes an antidepressant agent with the molecular formula C25H32ClN5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59H4FCV1TF, chemically known as 3h-1,2,4-triazol-3-one, 2,4-dihydro-2-3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-4-(2-phenoxyethyl)- but generally known as nefazodone, which bears US NIH Compound Identifier 4449. European Medicines Agency schedules Nefazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09180MIG. The term NEFAZODONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules nefazodone in its Anatomical Therapeutic Chemical (ATC) Classification. NEFAZODONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nefazodone under HS 29335995 and SITC 51576. As of Q4 2014, NEFAZODONE remains the US FDA Preferred Term for this commodity. Nefazodone bears US NLM identifiers UMLS ID C0068485 and NCI Concept Code C61859. SMILES: Clc1cc(N2CCN(CC2)CCCn2nc(n(c2=O)CCOc2ccccc2)CC)ccc1.